Valeant Pharmaceuticals reported $29.25B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Amgen AMGN:US $ 64993M 5220M
Ani Pharmaceuticals ANIP:US $ 470.45M 9.7M
Aphria Inc APH:CN C$ 2.81B 5.48M
Aurora Cannabis Inc ACB:CN 2.56B 44.42M
Biogen BIIB:US $ 23806.7M 663.7M
Bristol Myers Squibb BMY:US $ 110893M 96M
Canopy Growth Corp WEED:CN C$ 6.49B 475.73M
Catalent CTLT:US $ 10183M 1071M
Corcept Therapeutics CORT:US $ 585.4M 16.92M
Danaher DHR:US $ 82498M 4471M
Eli Lilly And LLY:US $ 48187M 378M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Gilead Sciences GILD:US $ 67098M 886M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Lannett LCI:US $ 690.87M 7.13M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Perrigo Ordinary Shares PRGO:US $ 10915.9M 314.4M
Phibro Animal Health PAHC:US $ 836.04M 5.28M
Prestige Brands PBH:US $ 3675.82M 116.7M
Revance Therapeutics RVNC:US $ 581.83M 59.05M
Supernus Pharmaceuticals SUPN:US $ 1555.04M 18.02M
Valeant Pharmaceuticals VRX:CN $ 29252M 790M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
Zoetis ZTS:US $ 13705M 364M